Diagnostic investigation and multidisciplinary management in motor neuron disease
Authors:
- 1 December 2005
- journal article
- review article
- Published by Springer Nature in Journal of Neurology
- Vol. 252 (12) , 1435-1447
Abstract
Amyotrophic lateral sclerosis (ALS) is the most common adult-onset motor neuron disease. ALS is a progressive neurodegenerative disorder, involving motor neurons in the cerebral cortex, brainstem and spinal cord, presenting with a combination of upper and lower motor neuron signs. Etiology remains undetermined, although a multifactorial origin is widely accepted including genetic factors, auto-immunity, oxidative stress, glutamate excitotoxicity and abnormal neurofilament aggregation. The absence of specific diagnostic testing, and variable clinical presentations make the diagnosis of ALS challenging, relying upon correlation of clinical, electrophysiological and neuroimaging data. The disease is relentlessly progressive, with dysarthria, dysphagia, tetraparesis, and respiratory insufficiency due to ongoing respiratory muscle paresis. There is no specific treatment for ALS. Riluzole, a glutamate antagonist, is the only FDA approved drug for ALS, but has only a modest effect on survival. The multiplicity and progressiveness of the disabilities in ALS, highlights the need for a coordinated multidisciplinary rehabilitation program managing symptoms, respiratory care, dysphagia and nutrition, dysarthria and communication, physical and occupational therapy. The main goals are to prolong independence, prevent complications and improve quality of life.Keywords
This publication has 95 references indexed in Scilit:
- A Mutation in the Vesicle-Trafficking Protein VAPB Causes Late-Onset Spinal Muscular Atrophy and Amyotrophic Lateral SclerosisThe American Journal of Human Genetics, 2004
- Identification of Two Novel Loci for Dominantly Inherited Familial Amyotrophic Lateral SclerosisThe American Journal of Human Genetics, 2003
- The Amyotrophic Lateral Sclerosis Center: A Model of Multidisciplinary ManagementCritical Reviews in Physical and Rehabilitation Medicine, 2003
- Palliative Care for Motor Neurone DiseasePractical Neurology, 2002
- A Novel Locus for Familial Amyotrophic Lateral Sclerosis, on Chromosome 18qThe American Journal of Human Genetics, 2002
- A Controlled Trial of Riluzole in Amyotrophic Lateral SclerosisNew England Journal of Medicine, 1994
- Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisNature, 1993
- Effectiveness of Exercise in Progressive Neuromuscular DiseaseNeurorehabilitation and Neural Repair, 1991
- Pathologic laughter and crying in ALS: a search for their originActa Neurologica Scandinavica, 1989
- Treatment of Pathologic Laughing and Weeping with AmitriptylineNew England Journal of Medicine, 1985